Cytokine gene expression in Walker 256: A comparison of variants A (aggressive) and AR (regressive)

Cytokine

Volumn 36, Issue 3-4, 2006, Pages 123-133

  De Almeida Salles Perroud, Ana Paula ^a   Ashimine, Rika ^a   De Castro, Glaucia Monteiro ^a   Guimarães, Fernando ^a   Vieira, Karla Priscila ^a   Aparecida Vilella, Conceição ^a   Samico Cavalcanti, Tereza Cristina ^a   Lima Zollner, Ricardo De ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cytokines; Immunomodulation; Walker 256

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL ISOLATION; CELL LINEAGE; CONTROLLED STUDY; GENE EXPRESSION; INFLAMMATORY INFILTRATE; MALE; MICROSCOPY; MONONUCLEAR CELL; NONHUMAN; OSMOTIC FRAGILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERUM; SPLEEN; SPLEEN WEIGHT; TUMOR CELL; TUMOR ESCAPE; TUMOR GROWTH; TUMOR VOLUME; WALKER CARCINOMA;

ANEMIA; ANIMALS; BODY WEIGHT; CARCINOMA 256, WALKER; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEMOGLOBINS; INTERFERON TYPE II; INTERLEUKIN-12; MALE; ORGAN SIZE; OSMOTIC FRAGILITY; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 33847227363     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.11.004     Document Type: Article

References (37)

1. Meyers R. Studies on tumor antigens of the Walker 256 carcinossarcoma. Immunochemistry 12 (1974) 589-595
2. Rettori O., Vieira-Matos A.N., and Tahin Q.S. Variability and discontinuity of the pathognomic systemic effects caused by The Walker -256 tumor progression in rats. Tumori 81 (1995) 370-377
3. Rettori O., Vieira-Matos N., and Gontijo J.A.R. Reduced renal sodium excretion in Walker -256 tumor bearing rats. Acta Physiol Latino Am 46 (1996) 111-118
4. Guimarães F., Rettori O., Vieira-Matos A.N., and Fernandes G.A. The influence of septal lesions on sodium and water retention induced by Walker 256. Braz J Med Biol Res 32 (1999) 309-317
5. Banyer J.L. Cytokines in innate and adaptative immunity. Rev Immunogenet 2 (2000) 359-373
6. Chouaib S. The host-tumor immune conflict: from immunossupression to resistance and destruction. Immunol Today 18 (1997) 493-497
7. Belardelli F., and Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol 23 (2002) 201-208
8. Aboseif S., El-Sakka A., Young P., and Cunha G. Mesenchymal reprogramming of adult human epithelial differentiation. Differentiation 65 (1999) 113-118
9. Guimarães F., Retori O., Vieira-Matos N.A., and Fernandes G.A. The influence of septal lesions on sodium and water retention induced by Walker 256 tumor. Braz J Med Biol Res 32 (1999) 309-317
10. Dacie J.V., Lewis S.M., and Gordon-Smith E.C. Investigation of hereditary haemolytic anaemias. In: Dacie J.V., and Lewis S.M. (Eds). Pratical Haematology (1984), Churchill Linvisgstone, Edinburgh 152-178
11. Chomczynsky P., and Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
12. Ventura-Oliveira D., Villela C.A., Zanin M.E., Castro G.M., Moreira Filho D.C., and Zollner R.L. Kinetics of TNF-α, 1991 and IFN-γ mRNA expression in islets and spleen of NOD mice. Braz J Med Biol Res 35 (2002) 1347-1355
13. Monteiro Castro G., Zanin M.E., Ventura Oliveira D., Villela C.A., Ashimine R., and Zollner R.L. Th1 and Th2 cytokine immunomodulation by gangliosides in experimental autoimune encephalomyelites. Cytokine 26 (2004) 155-163
14. Dunn G.P., Bruce A.T., Ikeda H., Old L.J., and Schereiber R.D. Cancer immunoediting from immunosurveillance to tumor escape. Nat Immunol 3 (2002) 991-998
15. Vido A.A., Cavalcanti T.C., Guimarães F., Vieira-Matos A.N., and Rettori O. The hemolytic component of cancer anemia: effects of osmotic and metabolic stress on the erythrocytes of rats bearing multifocal inoculations of the Walker 256 tumor. Braz J Med Biol Res 33 (2000) 815-822
16. Belardelli F., Ferrantini M., Proietti E., and Kirkwood J.M. Interferon-α in tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13 (2002) 119-134
17. Brunda M.J., Luistro L., Hendrzak J.A., Fountokoukis M., Garrotta G., and Gattely M.K. Role IFN-γ in mediating the antitumor efficacy of IL-12. J Immunother 17 (1995) 71-77
18. Nastala C.L., Edington H.D., Mckinney T.G., Tahara H., Nalesnick M.A., Brunda M.J., et al. Recombinant Il-12 administration induces tumor regression in association with IFN-γ production. J Immunol 153 (1994) 1697-1706
19. Young H.A., and Hardy K.J. Role of interferon γ in immne cell regulation. J Leukoc Biol 58 (1995) 373-381
20. Rajan P., Sodhi A., and Srivastava A. Cysplatin and interferon γ treated murine macrophages induce apoptosis in tumor cells lines. Anti-Cancer Drugs 8 (1997) 797-806
21. Stern A.S., Magram J., and Presley D.H. Interleukin-12 an integral cytokine in the immune response. Life Sci 58 (1996) 639-654
22. Schanoski A.S., Cavalcanti T.C., Campos C.B.L., Vieira-Matos A.N., Rettori O., and Guimarães F. Walker 256 MHC class I expression during shift from A variant to the immunogenic AR variant. Cancer Letters 211 (2004) 119-127
23. Simpkins H., and Lehman J.M. A morphological and phenotypic analysis of Walker 256 cells. Cancer Res 15 (1991) 1334-1338
24. Kubin M., Chow J.M., and Trinchieri G. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor α and IL-1β production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83 (1994) 1847-1855
25. Pierce D.F. Mamary tumor supression by transforming growth factor beta 1 transgene expresión. Proc Natl Acad Sci USA 92 (1995) 4254-4258
26. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 16 (2002) 87-96
27. Means R.T., and Krantz S.B. Progress in understanding the pathogenesis of anaemia of chronic disease. Blood 80 (1992) 1639-1644
28. Zoumbos N.C., Djeu J., and Young N.S. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes. J Immunol 133 (1984) 769-777
29. Wang C.Q., Udupa K.B., and Lipschitz D.A. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erytroid progenitor cell development. J Cell Physiol 162 (1995) 134-138
30. Fucks D., Hausen A., Reibnegger G., Werner E.R., Werner-Felmayer G., and Wachter H. Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol 46 (1991) 65-70
31. Dybedal I., Guan F., Borge O.J., Veiby O.P., Ramsfjell V., Nagata S., and Jacobsen S.E. Transforming growth factor-beta1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells. Blood 90 (1997) 3395-3403
32. Massage J. TGF-beta signal transduction. Annu Rev Biochem 67 (1998) 753-791
33. Pierce D.F. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1. Genes Dev 7 (1993) 2308-2317
34. Jhappan C. Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J 12 (1993) 1835-1845
35. Liotta L.C., and Kohn E.C. The microenvironment of the tumour - host interface. Nature 411 (2001) 375-379
36. Istfan N.W., Ling P.R., Blackburn G.L., and Bistrian B.R. Enhanced of tumor proteolysis by TNF-α: correlation of in vivo isotope estimates with growth. Amer Physiol Soc (1991) 106-116
37. Vaccariello M., Javaherian A., Wang Y., Fusenig N.E., and Garlick J.A. Cell interactions control the fate of malignant keranocytes in an organotypic model of early neoplasia. J Invest Dermatol 113 (1999) 384-391